Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl E Allen

Showing results (21-30 of 139) with videos related to

Pageof 14
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 10, 2011
Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesionsTricia L Peters, Kenneth L McClain, Carl E Allen
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2003
Inhibition of NF-kappaB by ZAS3, a zinc-finger protein that also binds to the kappaB motifJoung-Woo Hong, Carl E Allen, Lai-Chu Wu
BMC Immunology|August 24, 2002
The kappa B transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3/KRC: a site selection amplification binding studyCarl E Allen, Chi-ho Mak, Lai-Chu Wu
British Journal of Haematology|November 18, 2014
Up-front therapy for LCH: is it time to test an alternative to vinblastine/prednisone?Stephen J Simko, Kenneth L McClain, Carl E Allen
Pediatric Clinics of North America|December 2, 2014
Pediatric lymphomas and histiocytic disorders of childhoodCarl E Allen, Kara M Kelly, Catherine M Bollard
Hematology/Oncology Clinics of North America|October 14, 2015
Cell(s) of Origin of Langerhans Cell HistiocytosisMatthew Collin, Venetia Bigley, Kenneth L McClain, et al.
British Journal of Haematology|June 25, 2021
Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomesNader Kim El-Mallawany, Choladda V Curry, Carl E Allen
Pediatric Blood & Cancer|April 23, 2014
Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosisKai Lehmberg, Kenneth L McClain, Gritta E Janka, et al.
Pediatric Blood & Cancer|December 19, 2007
Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosisCarl E Allen, Xiaoying Yu, Claudia A Kozinetz, et al.
Hematology/Oncology Clinics of North America|March 25, 2025
Genomic Alterations in Langerhans Cell HistiocytosisNitya Gulati, Erin Peckham-Gregory, D Williams Parsons, et al.
Pageof 14

Showing results (21-30 of 139) with videos related to

Sort By:
Pageof 14
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 10, 2011
Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesionsTricia L Peters, Kenneth L McClain, Carl E Allen
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2003
Inhibition of NF-kappaB by ZAS3, a zinc-finger protein that also binds to the kappaB motifJoung-Woo Hong, Carl E Allen, Lai-Chu Wu
BMC Immunology|August 24, 2002
The kappa B transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3/KRC: a site selection amplification binding studyCarl E Allen, Chi-ho Mak, Lai-Chu Wu
British Journal of Haematology|November 18, 2014
Up-front therapy for LCH: is it time to test an alternative to vinblastine/prednisone?Stephen J Simko, Kenneth L McClain, Carl E Allen
Pediatric Clinics of North America|December 2, 2014
Pediatric lymphomas and histiocytic disorders of childhoodCarl E Allen, Kara M Kelly, Catherine M Bollard
Hematology/Oncology Clinics of North America|October 14, 2015
Cell(s) of Origin of Langerhans Cell HistiocytosisMatthew Collin, Venetia Bigley, Kenneth L McClain, et al.
British Journal of Haematology|June 25, 2021
Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomesNader Kim El-Mallawany, Choladda V Curry, Carl E Allen
Pediatric Blood & Cancer|April 23, 2014
Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosisKai Lehmberg, Kenneth L McClain, Gritta E Janka, et al.
Pediatric Blood & Cancer|December 19, 2007
Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosisCarl E Allen, Xiaoying Yu, Claudia A Kozinetz, et al.
Hematology/Oncology Clinics of North America|March 25, 2025
Genomic Alterations in Langerhans Cell HistiocytosisNitya Gulati, Erin Peckham-Gregory, D Williams Parsons, et al.
Pageof 14